Cardiovascular risk profile of patients with acute liver failure after liver transplantation when compared with the general population

Transplantation

Volumn 89, Issue 1, 2010, Pages 61-68

  Åberg, Fredrik ^a   Jula, Antti ^b   Höckerstedt, Krister ^a   Isoniemi, Helena ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Diabetes; Dyslipidemia; Hypertension; Long term complications; Obesity.

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; GLUCOSE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET RESTRICTION; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSLIPIDEMIA; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT DYSFUNCTION; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED FASTING GLUCOSE; INSULIN DEPENDENT DIABETES MELLITUS; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; RETRANSPLANTATION; RISK ASSESSMENT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CORONARY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; LIPIDS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; OBESITY; OVERWEIGHT; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS;

EID: 74549142381     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181bcd682     Document Type: Article

References (31)

1. Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation 2006; 82: 603.
2. Appleton CP, Hurst RT, Lee KS, et al. Long-term cardiovascular risk in the orthotopic liver transplant population. Liver Transpl2006; 12: 352.
3. Johnston SD, Morris JK, Cramb R, et al. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002; 73: 901.
4. Silverborn M, Jeppsson A, Mårtensson G, et al. New-onset cardiovascular risk factors in lung transplant recipients. J Heart Lung Transplant 2005; 24: 1536.
5. Deng MC. Cardiac transplantation. Heart 2002; 87: 177.
6. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. NEngl JMed 2004; 351: 1296.
7. Muñoz SJ, Elgenaidi H. Cardiovascular risk factors after liver transplantation. Liver Transpl 2005; 11(11 suppl 2):S52.
8. Reuben A. Long-term management of the liver transplant patient: Diabetes, hyperlipidemia, and obesity. Liver Transpl 2001; 7(11 suppl 1): S13.
9. Mehta SH, Brancati FL, Sulkowski MS, et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592.
10. Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: Direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126: 840.
11. Allison ME, Wreghitt T, Palmer CR, et al. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994; 21: 1135.
12. Mells G, Neuberger J. Reducing the risks of cardiovascular disease in liver allograft recipients. Transplantation 2007; 83: 1141.
13. Ichai P, Samuel D. Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl 2008; 14(suppl 2): S67.
14. Kramer DJ, Canabal JM, Arasi LC. Application of intensive care medicine principles in the management of the acute liver failure patient. Liver Transpl2008; 14(suppl 2): S85.
15. The National Health 2000 Health Examination Survey home page. Available at: http://www. terveys2000. fi/indexe. html. Accessed February 2009.
16. World Health Organisation. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva, World Health Organisation, Department of Noncommunicable Disease Surveillance, 1999, p 1.
17. Navasa M, Bustamante J, Marroni C, et al. Diabetes mellitus after liver transplantation: Prevalence and predictive factors. J Hepatol 1996; 25: 64.
18. Neal DA, Tom BD, Luan J, et al. Is there disparity between risk and incidence of cardiovascular disease after liver transplant? Transplantation 2004; 77: 93.
19. Stegall MD, Everson G, Schroter G, et al. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Transplantation 1995; 60: 1057.
20. Fernandez-Miranda C, Sanz M, dela Calle A, et al. Cardiovascular risk factors in 116 patients 5 years or more after liver transplantation. Transpl Int 2002; 15: 556.
21. Bianchi G, Marchesini G, Marzocchi R, et al. Metabolic syndrome in liver transplantation: Relation to etiology and immunosuppression. Liver Transpl 2008; 14: 1648.
22. Sheiner PA, Magliocca JF, Bodian CA, et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 2000; 69: 781.
23. Devlin J, Williams R, Neuhaus P, et al. Renal complications and development of hypertension in the European study of FK 506 and cyclosporin in primary liver transplant recipients. Transpl Int 1994; 7(suppl 1): S22.
24. Dikow R, Degenhard M, Kraus T, et al. Blood pressure profile and treatment quality in liver allograft recipients-benefit of tacrolimus versus cyclosporine. Transplant Proc 2004; 36: 1512.
25. Heisel O, Heisel R, Balshaw R, et al. New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis. Am J Transplant 2004; 4: 583.
26. Saliba F, Lakehal M, Pageaux GP, et al. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: An observational multicenter study. Liver Transpl 2007; 13: 136.
27. Bigam DL, Pennington JJ, Carpentier A, et al. Hepatitis C-related cirrhosis: A predictor of diabetes after liver transplantation. Hepatology 2000; 32: 87.
28. Selberg O, Burchert W, vd Hoff J, et al. Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism. J Clin Invest 1993; 91: 1897.
29. Perseghin G, Mazzaferro V, Sereni LP, et al. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: Effect of liver transplantation. Hepatology 2000; 31: 694.
30. Peltonen M, Harald K, Männistö S, et al. The National FINRISK 2007 Study. Helsinki, Finland: Publications of the National Public Health Institute; 2008. Series B 34/2008.
31. Niemi M, Winell K. Diabetes Suomessa-Esiintyvyys ja hoidon laadun vaihtelu. [Diabetes in Finland-Prevalence and variation in quality of care (In Finnish)] Helsinki, Finland: Stakes; Diabetesliitto; 2005. Rap-ortteja No. 8/2005.